Sally C. Pipes
Featured
NEW BRIEF: Expanding “Buy America” Rules Would Hurt U.S. Patients and Economy, Hinder Development of Coronavirus Vaccine
Expanding “Buy America” rules for prescription drugs and medical supplies would reduce patient access to drugs and further damage the economy, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to download the brief “As the U.S. ...
Commentary
Joe Biden is no moderate, especially on healthcare
After months of campaigning, Joe Biden has emerged as the presumptive Democratic presidential nominee. Last week, he finally secured the endorsement of his chief rival, Sen. Bernie Sanders. Biden succeeded by positioning himself as a moderate alternative to Sanders and other Democratic candidates. But Biden’s agenda is anything but moderate. Just look at his healthcare ...
Commentary
Ten years with Obamacare: why it won’t make it to next year
The Affordable Care Act marks its 10th anniversary this year. And ten years later, the law has failed to live up to its name. The last decade has seen insurance premiums soar and coverage options dwindle for millions of people. The share of Americans without insurance is on the rise, ...
Commentary
Slashing Red Tape Can Ease The Doctor Shortage
The coronavirus pandemic is threatening to stretch many hospitals to their breaking point. Beds are filling up with stricken patients, and public health officials are concerned about whether we’ll have enough doctors and other healthcare professionals to care for them. So they’re scrambling to roll back years’ worth of regulations ...
Commentary
Fighting coronavirus – billionaires, private sector deserve thanks for medical progress
Bill Gates announced on April 2 that his foundation would fund the construction of facilities to produce seven possible coronavirus vaccines. The Microsoft founder acknowledges that only two of those vaccines will likely succeed – and the foundation will thus waste billions of dollars on the failed candidates. That’s a small ...
Coronavirus
The Pat Miller Show Talks to Sally C. Pipes on Private Sector Role in Coronavirus Fight
Sally C. Pipes joined the the Pat Miller Show in Cincinnati, Ohio to discuss the enormous benefits of the American private sector in the fight against the coronavirus epidemic. Pipes breaks down how the private sector industries in the United States are pushing innovations in the fight against the coronavirus ...
Coronavirus
Sally C. Pipes Talks Coronavirus, Telehealth Benefits on the Jim Bohannon Show
The Jim Bohannon Show interviews Sally C. Pipes about the latest news on the coronavirus pandemic, including the expanded use of telehealth for underserved and rural areas. Pipes explains the importance of telehealth as we start to move past COVID-19 and the role telehealth could pay in more affordable health ...
Commentary
Coronavirus deregulating health care — this should continue after pandemic is beaten
In response to the coronavirus outbreak, the Centers for Medicare and Medicaid Services has rolled back regulations on hospitals and health care providers. Hospitals are no longer barred from treating COVID-19 patients in outpatient facilities. The feds are also freeing nurse practitioners, physician assistants and medical residents to provide more care on their own. ...
Commentary
Telehealth should stay long after COVID-19 goes
The new coronavirus outbreak has put enormous pressure on the American health care system. In response, federal officials and private insurers have rushed to improve patient access to video consultations and other forms of virtual care. It may have taken a public health emergency to bring “telehealth” to the mainstream, ...
Drug Pricing
Sally C. Pipes Explains the Danger of Drug Price Controls with Coronavirus
PRI’s Sally C. Pipes, President, CEO, and Thomas W. Smith Fellow in Health Care Policy, joined the Kirby Nation to discuss the danger of drug price controls and American medical innovation. Pipes explains that roughly 4,500 new drugs are in various stage of development, with an estimated three-quarters of those ...
NEW BRIEF: Expanding “Buy America” Rules Would Hurt U.S. Patients and Economy, Hinder Development of Coronavirus Vaccine
Expanding “Buy America” rules for prescription drugs and medical supplies would reduce patient access to drugs and further damage the economy, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to download the brief “As the U.S. ...
Joe Biden is no moderate, especially on healthcare
After months of campaigning, Joe Biden has emerged as the presumptive Democratic presidential nominee. Last week, he finally secured the endorsement of his chief rival, Sen. Bernie Sanders. Biden succeeded by positioning himself as a moderate alternative to Sanders and other Democratic candidates. But Biden’s agenda is anything but moderate. Just look at his healthcare ...
Ten years with Obamacare: why it won’t make it to next year
The Affordable Care Act marks its 10th anniversary this year. And ten years later, the law has failed to live up to its name. The last decade has seen insurance premiums soar and coverage options dwindle for millions of people. The share of Americans without insurance is on the rise, ...
Slashing Red Tape Can Ease The Doctor Shortage
The coronavirus pandemic is threatening to stretch many hospitals to their breaking point. Beds are filling up with stricken patients, and public health officials are concerned about whether we’ll have enough doctors and other healthcare professionals to care for them. So they’re scrambling to roll back years’ worth of regulations ...
Fighting coronavirus – billionaires, private sector deserve thanks for medical progress
Bill Gates announced on April 2 that his foundation would fund the construction of facilities to produce seven possible coronavirus vaccines. The Microsoft founder acknowledges that only two of those vaccines will likely succeed – and the foundation will thus waste billions of dollars on the failed candidates. That’s a small ...
The Pat Miller Show Talks to Sally C. Pipes on Private Sector Role in Coronavirus Fight
Sally C. Pipes joined the the Pat Miller Show in Cincinnati, Ohio to discuss the enormous benefits of the American private sector in the fight against the coronavirus epidemic. Pipes breaks down how the private sector industries in the United States are pushing innovations in the fight against the coronavirus ...
Sally C. Pipes Talks Coronavirus, Telehealth Benefits on the Jim Bohannon Show
The Jim Bohannon Show interviews Sally C. Pipes about the latest news on the coronavirus pandemic, including the expanded use of telehealth for underserved and rural areas. Pipes explains the importance of telehealth as we start to move past COVID-19 and the role telehealth could pay in more affordable health ...
Coronavirus deregulating health care — this should continue after pandemic is beaten
In response to the coronavirus outbreak, the Centers for Medicare and Medicaid Services has rolled back regulations on hospitals and health care providers. Hospitals are no longer barred from treating COVID-19 patients in outpatient facilities. The feds are also freeing nurse practitioners, physician assistants and medical residents to provide more care on their own. ...
Telehealth should stay long after COVID-19 goes
The new coronavirus outbreak has put enormous pressure on the American health care system. In response, federal officials and private insurers have rushed to improve patient access to video consultations and other forms of virtual care. It may have taken a public health emergency to bring “telehealth” to the mainstream, ...
Sally C. Pipes Explains the Danger of Drug Price Controls with Coronavirus
PRI’s Sally C. Pipes, President, CEO, and Thomas W. Smith Fellow in Health Care Policy, joined the Kirby Nation to discuss the danger of drug price controls and American medical innovation. Pipes explains that roughly 4,500 new drugs are in various stage of development, with an estimated three-quarters of those ...
